Boston Sci to pay J&J $716 million to settle suits
NEW YORK (Reuters) - Boston Scientific Corp will pay Johnson & Johnson 6 million to settle more than a dozen patent dispute lawsuits involving coronary stents and other heart devices, the companies said on Tuesday.